CYTEK BIOSCIENCES, INC. (CTKB) Net margin 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) net profit margin by fiscal year — reported net income divided by reported revenue.
-33.0%FY2025 · since FY2020: 20.9% → -33.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -33.0% | -30.0 pp |
| FY2024 | -3.0% | +3.3 pp |
| FY2023 | -6.3% | -7.8 pp |
| FY2022 | 1.5% | -0.9 pp |
| FY2021 | 2.4% | -18.5 pp |
| FY2020 | 20.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice